
| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | BENDHEIM JACK | Director & President and CEO | Sale | 7,040 | $52.76 | $371K | 74.8K | View ↗ | |
| 2026-04-29 | BENDHEIM JACK | Director & President and CEO | Sale | 7,040 | $52.92 | $373K | 81.8K | View ↗ | |
| 2026-04-28 | BENDHEIM JACK | Director & President and CEO | Sale | 7,040 | $55.91 | $394K | 88.8K | View ↗ | |
| 2026-04-23 | BENDHEIM JACK | Director & President and CEO | Sale | 7,040 | $54.09 | $381K | 95.9K | View ↗ | |
| 2026-04-22 | BENDHEIM JACK | Director & President and CEO | Sale | 7,040 | $54.29 | $382K | 102.9K | View ↗ |
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net sales | $1.30B+27.4% | $1.02B+4.1% | $977.9M+3.8% | $942.3M+13.1% | $833.4M |
| Cost of goods sold | -$896.3M-27.2% | -$704.6M-3.7% | -$679.7M-203.5% | $656.9M+16.9% | $562.0M |
| Gross profit | $399.9M+27.7% | $313.1M+5.0% | $298.2M+4.5% | $285.4M+5.2% | $271.4M |
| Selling, general and administrative expenses | $289.5M+11.4% | $259.8M+14.7% | $226.4M+9.7% | $206.4M+5.0% | $196.5M |
| Operating income | $110.5M+107.2% | $53.3M-25.8% | $71.8M-9.0% | $79.0M+5.5% | $74.9M |
| Interest expense, net | $34.6M+86.7% | $18.5M+21.0% | $15.3M+29.0% | $11.9M-7.8% | $12.9M |
| Foreign currency losses, net | $7.9M-67.0% | $23.9M+872.0% | $2.5M | — | — |
| Income before income taxes | $68.0M+522.9% | $10.9M-79.8% | $54.1M-25.2% | $72.3M+8.8% | $66.5M |
| Provision for income taxes | $19.7M+132.1% | $8.5M-60.4% | $21.5M-7.3% | $23.2M+91.6% | $12.1M |
| Net income | $48.3M+1897.7% | $2.4M-92.6% | $32.6M-33.7% | $49.2M-9.6% | $54.4M |
| basic (in dollars per share) | $1K+1883.3% | $60-92.6% | $810-33.1% | $1K-9.7% | $1K |
| diluted (in dollars per share) | $1K+1883.3% | $60-92.6% | $810-33.1% | $1K-9.7% | $1K |
| basic (in shares) | $40.5M+0.0% | $40.5M+0.0% | $40.5M+0.0% | $40.5M+0.1% | $40.5M |
| diluted (in shares) | $40.7M+0.4% | $40.5M+0.0% | $40.5M+0.0% | $40.5M+0.0% | $40.5M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
PAHC vs. PODD: Which Stock Is the Better Value Option?
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million